Applications for the annual Glaucoma Australia ‘Quinlivan’ Research Grants have opened, with successful recipient(s) to be unveiled on World Sight Day on 10 October 2024.
Glaucoma Australia CEO Mr Adam Check said the organisation was grateful to the late benefactor Mr Marcus Quinlivan and his family for their “generosity and dedication to glaucoma research”.
Last years’ recipients were Western Australian ophthalmologist Professor David Mackey and co-investigator and Postdoctoral Research Fellow Dr Samantha Lee, who are investigating the normal range of intraocular pressure (IOP) in children and young adults, and whether it predicts glaucoma later in life
“The Glaucoma Australia ‘Quinlivan’ Research Grants have made significant contributions to Australian medical and social research into glaucoma. We are now very proud to announce applications are open for the 2024 round of our ‘Quinlivan’ Research Grants which will continue to fund research that supports our mission,” Check said.
Chair of Glaucoma Australia Research Committee, Professor Bang Bui, emphasised the organisation’s commitment to high-quality glaucoma research in Australia.
“The broad aims of research we support are to improve the lives of people with glaucoma through better glaucoma detection and treatment. We are excited to facilitate the innovative research of academics who drive progress in glaucoma management,” said Dr Bui.
Established in 2006 by the late Mr Marcus Quinlivan in honour of his father, the William A Quinlivan Research Fund is said to be instrumental in advancing glaucoma research in Australia.
To date, Glaucoma Australia has allocated over $1.7 million towards glaucoma research aimed at enhancing the quality-of-life for individuals diagnosed with glaucoma through improved detection, treatment and monitoring.
In the current funding round, Glaucoma Australia has pledged to invest up to $200,000, anticipating between one and four grants to be awarded. All projects are expected to be completed within three years of grant allocation, and seed fund grants can be utilised to apply for further funding with NHMRC or other agencies.
Glaucoma Australia is dedicated to supporting research focused on four key domains:
1. Increasing the rate and reliability of early detection of glaucoma
2. Developing new treatments or improving the treatment experience
3. Improving the quality and experience of monitoring the condition progression and maintaining better population wide statistics
4. Providing prevention or management tools to improve the quality of life for people with glaucoma.
Applications will be accepted from 1 May 2024, until 5 pm (AEST) on Friday 14 June 2024. Interested applicants can apply by visiting Glaucoma Australia’s website www.glaucoma.org.au/i-treat-glaucoma/quinlivan-research-grants.
More reading
Mike Amor joins Glaucoma Australia as ambassador
SiGHTWiSE: Glaucoma Australia gives patient support program a new name
Glaucoma Australia says economic impact of disease could top $4.3 billion
